Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers
about
Prevention of Community-Acquired Pneumonia with Available Pneumococcal VaccinesDirect effect of 10-valent conjugate pneumococcal vaccination on pneumococcal carriage in children BrazilReduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil.The dichotomy of pathogens and allergens in vaccination approachesFractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study.Incidence of Hospitalized Pneumococcal Pneumonia among Adults in Guatemala, 2008-2012.Monitoring of timely and delayed vaccinations: a nation-wide registry-based study of Norwegian children aged < 2 years.Impact of Pneumococcal Conjugate Universal Routine Vaccination on Pneumococcal Disease in Italian Children.Current Recommendations for Pneumococcal Vaccination of Children and AdultsThe Clinical Effectiveness of Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Cord blood Streptococcus pneumoniae-specific cellular immune responses predict early pneumococcal carriage in high-risk infants in Papua New Guinea.Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia.Maternal and neonatal pneumococcal vaccination - where are we now?Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned.Neonatal invasive pneumococcal disease: New Zealand experience in the era of pneumococcal vaccination.Pneumonia in Elderly Australians: Reduction in Presumptive Pneumococcal Hospitalizations but No Change in All-Cause Pneumonia Hospitalizations Following 7-Valent Pneumococcal Conjugate Vaccination.Effect of maternally-derived anti-protein and anti-capsular IgG antibodies on the rate of acquisition of nasopharyngeal carriage of pneumococcus in newborns.Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination.
P2860
Q28077703-C0227029-5405-46B3-9AEB-3EAF79A5F812Q33706645-739BD3E1-A0A8-49CC-97C2-5900C5FC2667Q33778646-687AD2A6-DDE8-46B6-8604-922BFA05870FQ33909251-25C12299-4875-471A-9CC2-FC30AAC9F3BCQ34530710-A67E9D8D-5407-4F29-8152-30CA4E34F57EQ35816192-6C936663-4CA7-4E25-9B87-1011D752A86FQ35840208-F16F0C74-FF0F-4C2D-9F7A-4A65B5EB8169Q36006193-66D613EE-04B3-456A-AC92-3B8E78289B02Q36555871-531234D4-CAD5-441F-89BF-0608BE65E371Q36713715-543DA952-DD80-4B4F-ADDE-D08F9B153B7EQ37622565-540EC7F9-2D71-4001-B482-66D51648269FQ37631215-B4DEDC2C-912B-4D81-A2F5-3A2D9C35D2E5Q38948154-1B94A7C7-9E75-4ACC-A71B-5D48FC18269AQ38966571-DC4E2C4A-1552-42F2-96CF-7EF20914752BQ39484402-47800AE4-1D3F-40F0-9193-6F4174085236Q40844795-E962DD47-5986-4880-8458-445D13FC6D8FQ41987151-0CBA8135-9804-4FDC-83AF-49060E2D417EQ42701700-AD8CA0CF-EFD7-442D-93D0-AE91A0D932CC
P2860
Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers
@en
Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers.
@nl
type
label
Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers
@en
Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers.
@nl
prefLabel
Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers
@en
Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers.
@nl
P2860
P1476
Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers
@en
P2093
Cynthia G Whitney
P2860
P304
P356
10.1097/INF.0000000000000076
P478
33 Suppl 2
P577
2014-01-01T00:00:00Z